NSE filing, NSE: AXISBANK. Summary written from the filing by ALFA Finder's alert engine.
Axis Bank Ltd: key numbers
- Share price
- ₹1,220.00
- Market cap
- ₹3,79,897 Cr
- Revenue (annual)
- ₹1,32,538 Cr
- Net profit (annual)
- ₹26,385 Cr
- P/E (TTM)
- 12.7×Sector 19.7×
- Promoter holding
- 7.86%-0.01% QoQ
- FII holding
- 38.05%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Axis Bank Ltd
All →Axis Bank Employee Stock Options
Axis Bank allotted 47,781 equity shares under its ESOP/RSU scheme. This allotment increases the bank's paid-up share capital.
Axis Bank Earnings Call Transcript: Key Takeaways
Axis Bank delivered robust credit growth and asset quality, though margins were optically compressed by FCNR deposit mobilization.
Axis Bank Management Change
Axis Bank has appointed Rahul Shukla as Group Head, Commercial and Bharat Banking, effective October 19, 2026. He will join the Bank's Senior Management team.
Axis Bank Other Announcement
Axis Bank reported no fund-raising activities or deviations in the use of issue proceeds for the quarter ended September 30, 2026, as per SEBI regulations.
Axis Bank Results Update
Axis Bank released its financial results highlights for the quarter ended September 30, 2026, reporting growth in deposits, advances, and net profit.
Axis Bank Q2 FY27 Results: Net Profit ₹7,705 Cr, Up 39.4% YoY
Axis Bank Ltd reported revenue from operations of ₹38,088 Cr (+17.9% YoY) and net profit of ₹7,705 Cr (+39.4% YoY) for Q2 FY27.
- Key figure
- Net profit ₹7,705 Cr · +39.4% YoY
Other employee stock options announcements
All →RateGain Travel Technologies Employee Stock Options
RateGain granted 53,021 Stock Appreciation Rights under its SAR Scheme 2022 at ₹800 and ₹862.25 per unit. The grants vest over four years and are exercisable within three years of vesting.
- Execution
- Vesting over 4 years (10% Y1, 20% Y2, 30% Y3, 40% Y4); exercisable within 3 years of vesting
Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.